03 July 2021
The third day of the 6th World Psoriasis and Psoriatic Arthritis Conference (WPPAC) 2021 features plenary sessions on hot topics like comorbidities, prevention, and long-term use of biologics. There are also two more keynote lectures, oral abstracts, and a new theme-of-the-day for the Complementary Program.
Interactive discussion session
This session’s topic is adressing unmet needs in psoriasis and psoriatic arthritis. The first part of the session session features patient expert Paul Mendoza, Professor Christopher Ritchlin, and Prof. Dr. Ricardo Romiti. In the second part of the session, Professors Ncoza Dlova and Matthias Augustin deliver lectures on addressing stigma. In an innovative online format featuring live participation from speakers located around the world, these lectures are followed by a live interactive discussion.
“Hot topic” session
This session is designed to approach the pros and cons of a “hit early, hit hard” treatment strategy. Professor Lluis Piug on the pro side and Professor Robert Gniadecki on the con side present the different views and end with a live, interactive discussion where conference attendees can participate.
Plenary and interactive Q&A sessions
The first plenary session of Day 4 is on topical therapy. First, Professor Lars Iversen discusses whether there is still a place for topical treatment. Then, Professor Mark Lebwohl presents new topical developments. Finally, Professor Wolfgang Weger speaks about measures to improve adherence to topical treatment. The speakers participate in a live Q&A after their talks.
This plenary session addresses one of the hot topics of this year: the consequences of the corona pandemic on the management of psoriasis and psoriatic arthritis. In this session Professor Jo Lambert lectures about whether early registry data are helpful for risk assessment, and Professor Paolo Gisondi talks about SARS-CoV-2 vaccination management in psoriasis and psoriatic arthritis.
Dr. Curdin Conrad from Switzerland speaks and answers questions about the hot topic of psoriasis, psoriatic arthritis, and infectious disease.
The Complementary Program is primarily directed at allied health professionals, non-specialists, patient leaders, and industry representatives. The final session of the complementary program is presented by the International Psoriasis Council (IPC) on the theme of latest research and updates.
Session 7 of the Complementary Program gives an update on the latest research on psoriasis. Professor Lone Skov gives a welcome and introduction followed by an overview of IPC’s disease severity classification and what it means in the clinic. Then, Professor Alexander Navarini talks about the future of teledermatology and Professor Jo Lambert discusses psoriasis and diet. The session ends with a live Q&A and closing comments.
The best poster presentations are recognized in a short ceremony. The conference abstracts present groundbreaking developments in the field of psoriasis and psoriatic arthritis.
IFPA’s 50th Anniversary and Awards
IFPA presents a celebration of the organizations 50th anniversary to honor its history and bestow awards upon individuals who made invaluable contributions over the past 5 decades.
You can still revisit all the groundbreaking content on demand until October! Register now to access recorded lectures, posters, exhibits, and research.
Poster abstracts are available online from Wednesday, June 30. Don’t forget your last chance to stop by the virtual abstract hall to learn about the very latest research on psoriasis and psoriatic arthritis.
Theme: “Connected, informed, and united to improve multidisciplinary care for people with psoriasis & psoriatic arthritis”
Dates: June 30 – July 3, 2021
Venue: Virtual Conference broadcast from Stockholm, Sweden
Target group: Dermatologists, rheumatologists and general practitioners and allied health professionals with an interest in psoriasis and psoriatic arthritis
Twitter: @PsoriasisIFPA, #WPPAC21
Camille Lancelot, IFPA Communications Manager.
Telephone: +46 73 961 15 65